Celyad Oncology sells 28.8% shares to Fortress Group for $32.5mn
BRUSSELS, BELGIUM: Celyad Oncology SA has entered into a subscription agreement with an affiliate of Fortress Investment Group for the private placement of 6.5 million ordinary shares for gross proceeds of USD 32.5 million (about EUR 28.7 million). The subscription…